In our previous in vitro experimental settings involving hepatic stellate cells (LX-2) and hepatocytes (Hepa-RG), HE treatment downregulated the expression of critical fibrogenic markers, including α-SMA and COL1A1. The gene discussed is ACTA1; the disease is hereditary elliptocytosis.